Roche’s RoActemra beats Humira in arthritis study
March 5, 2012Research and Development, Sales and Marketing Humira, RA, RoActemra, Roche, arthritis
Roche’s rheumatoid arthritis drug RoActemra has beaten Abbott’s Humira in a head-to-head study. The Phase IV trial showed that RoActemra …
Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC
March 2, 2012Research and Development
Catalent becomes #2 global clinical trial supply solutions provider
Chiltern welcomes Krista Stephenson to the global resourcing solutions team
March 2, 2012Research and Development
London, UK, February 28, 2012: Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Krista Stephenson has …
inVentiv Health launches Super Agency
March 2, 2012Medical Communications PR, iHCE, inVentiv, inVentiv Health Communications/Europe
inVentiv Health Communications/Europe (iHCE) has opened new headquarters in London which will serve as a hub for all European operations …
inVentiv Health hires Tom Sebok to lead companies within advertising group
March 2, 2012Medical Communications, Sales and Marketing GSW, Ignite, Tom Sebok, inVentic Health
inVentiv Health has announced that Tom Sebok will be leading the company’s advertising segment as the new president of inVentiv …
Mini-labs to fight counterfeit drugs in Africa
March 2, 2012Sales and Marketing Africa, Merck KGaA, Zambia, counterfeits
Merck KGaA is donating equipment which can detect counterfeit drugs, while also increasing its commitment to eradicating schistosomiasis in Africa. …
Good Pharmacovigilance Practice modules released by European Medicine Agency
March 1, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV
The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation. …
Pharma’s international code of conduct extended
March 1, 2012Medical Communications, Sales and Marketing Code of Practice, IFPMA, code of conduct
Pharma companies must adhere to a new stronger code of practice, no matter where they are in the world. The …
Academic alliances to speed Lilly’s R&D
March 1, 2012Research and Development, Sales and Marketing R&D, academia, break through drugs, collaboration, lilly
Lilly has unveiled a range of collaborations with academic researchers which it says will help it discover and develop more …
AstraZeneca announces several non-executive moves
March 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, appointments
AstraZeneca has announced that Leif Johansson is set to be elected as a non-executive director in April, with the intention …
Novartis appoints Brian McNamara to division head of OTC business
March 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC
Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …
‘Rare Disease Day’ highlights need for research
February 29, 2012Research and Development, Sales and Marketing Genzyme, Rare Disease Day, Shire
Today has been designated as Rare Disease Day around the world, with researchers, regulators and the industry all raising awareness …
A wake-up call for big pharma
February 29, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, McKinsey, business models, pharma
The good old days of the pharmaceutical industry are gone forever. Even an improved global economic climate is unlikely to …
Abbott buys into Galapagos’ RA candidate
February 29, 2012Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF
Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …
Shire signs antibody research deal with arGEN-X
February 29, 2012Research and Development Shire, arGEN-X, monoclonal antibodies
Shire has signed a deal with antibody specialists arGEN-X to develop drugs for rare genetic diseases.Rotterdam-based arGEN-X will use its …
LEO Pharma appoints new executive vice president
February 29, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing LEO Pharma, supply chain
From March Anders Spohr will take over the position of executive vice president for global product supply at LEO Pharma. …
NHS must adopt new technologies faster, says minister
February 28, 2012Research and Development ABPI, NHS, Whitehead, Willetts, innovation
The NHS needs to speed up its adoption of new technology, according to universities and science minister David Willetts. Echoing …
ICON acquires market access consultancy
February 28, 2012Research and Development CRO, ICON, pharma market access, pricing and reimbursement
ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …
Doctors don’t want rationing responsibility, finds survey
February 28, 2012Sales and Marketing Commissioning Board, NHS, NHS reforms, NHSCB, NICE, rationing
A survey of GPs in England has found that most do not want powers to ration care for NHS patients.The …
Jon Linscott to head PAN Advertising
February 28, 2012Business Services, Medical Communications, Sales and Marketing Creston Health, Jon Linscott, Pan Advertising
Jon Linscott has been appointed managing director of PAN Advertising, a member of the Creston Health group of companies. Linscott …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
